July 11, 2024
A D.C. federal judge on Thursday seemed skeptical about Vanda Pharmaceuticals' claims that waiting for the U.S. Food and Drug Administration to review its challenge to the agency's approval of a generic challenger to its sleep medication would seriously jeopardize the company's future.
September 26, 2023
Vanda Pharmaceuticals Inc. has hit federal drug regulators with a lawsuit claiming they wrongly gave the green light to an application on a generic version of the company's brand-name sleep drug Hetlioz, saying the government "turned a blind eye to" problems in the generic drug's studies.